Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
Published April 1, 2026 · Recall initiated: March 16, 2026
Summary
FDA records drug Class II recall D-0418-2026, published April 1, 2026 and initiated March 16, 2026. Recalling firm: Amerisource Health Services LLC; Status: Ongoing; Reported quantity: 697 cartons; Lot: Lot #1024852; Exp 9/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed tablet specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email if MECLIZINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MECLIZINE HYDROCHLORIDE
- Manufacturer
- Amerisource Health Services LLC
- Distributor
- U.S. Nationwide
- Lot
- Lot #1024852; Exp 9/30/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOctreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL vial inApril 1, 2026
- FDAChilli Spanish Peanuts, First Street brand, 11oz clear plastic container. UPC: None Item Code: 2608-T20April 1, 2026
- FDAOctreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial inApril 1, 2026
- FDAMeclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cardsJune 15, 2022
- FDAMeclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only,April 6, 2022
- FDAMeclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: JubilantNovember 22, 2017
Questions about this recall
Was Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217. recalled?
Yes. FDA published recall D-0418-2026 on April 1, 2026. Reported hazard: Failed tablet specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MECLIZINE HYDROCHLORIDE.